Larvol Delta - Bioventus-Receives-Authorization-to-Proceed-Under-Investigational-New-Drug-Application-for-Clinical-Trial-of-Placental-Tissue-Particulate-PTP001-for-the-Treatment-of-Knee-OA

Motys (PTP-001) - Bioventus

https://www.businesswire.com/news/home/20201118005130/en/Bioventus-Receives-Authorization-to-Proceed-Under-Investigational-New-Drug-Application-for-Clinical-Trial-of-Placental-Tissue-Particulate-PTP-001-for-the-Treatment-of-Knee-OA

Nov 18, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next